Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Jan;39(1):439–444. doi: 10.1128/iai.39.1.439-444.1983

Toxicity of staphylococcal alpha toxin for rabbit alveolar macrophages.

M P McGee, A Kreger, E S Leake, S Harshman
PMCID: PMC347958  PMID: 6822424

Abstract

Highly purified staphylococcal alpha toxin was toxic in vitro for rabbit alveolar macrophages. Cytotoxicity, manifested by loss of the ability to exclude trypan blue dye and by morphological evidence of cell necrosis and lysis, was observed after exposure for 4 h to 1 microgram of toxin preparation per ml and after exposure for 8 h to 0.1 microgram of toxin per ml. In addition, exposure to toxin under conditions which did not kill more than 10% of the cells (1 microgram/ml for 1.5 to 2 h) significantly reduced the phagocytic activity of the cells and their ability to respond to an activator of hexose monophosphate shunt activity.

Full text

PDF
439

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlam C., Ward P. D., McCartney A. C., Arbuthnott J. P., Thorley C. M. Effect immunization with highly purified alpha- and beta-toxins on staphylococcal mastitis in rabbits. Infect Immun. 1977 Aug;17(2):250–256. doi: 10.1128/iai.17.2.250-256.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andersen B. R., Duncan J. L. Activation of human neutrophil metabolism by streptolysin O. J Infect Dis. 1980 May;141(5):680–685. doi: 10.1093/infdis/141.5.680. [DOI] [PubMed] [Google Scholar]
  3. Cassidy P., Harshman S. Purification of staphylococcal alpha-toxin by adsorption chromatography on glass. Infect Immun. 1976 Mar;13(3):982–986. doi: 10.1128/iai.13.3.982-986.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cassidy P., Harshman S. Studies on the binding of staphylococcal 125I-labeled alpha-toxin to rabbit erythrocytes. Biochemistry. 1976 Jun 1;15(11):2348–2355. doi: 10.1021/bi00656a016. [DOI] [PubMed] [Google Scholar]
  5. DeChatelet L. R., Shirley P. S., Johnston R. B., Jr Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood. 1976 Apr;47(4):545–554. [PubMed] [Google Scholar]
  6. Espersen F., Gabrielsen J. Pneumonia due to Staphylococcus aureus during mechanical ventilation. J Infect Dis. 1981 Jul;144(1):19–23. doi: 10.1093/infdis/144.1.19. [DOI] [PubMed] [Google Scholar]
  7. Graham R. C., Jr, Karnovsky M. J., Shafer A. W., Glass E. A., Karnovsky M. L. Metabolic and morphological observations on the effect of surface-active agents of leukocytes. J Cell Biol. 1967 Mar;32(3):629–647. doi: 10.1083/jcb.32.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Holmes B., Page A. R., Good R. A. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest. 1967 Sep;46(9):1422–1432. doi: 10.1172/JCI105634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kapral F. A. Factors involved in experimental staphylococcal peritonitis. Ann N Y Acad Sci. 1965 Jul 23;128(1):259–273. doi: 10.1111/j.1749-6632.1965.tb11643.x. [DOI] [PubMed] [Google Scholar]
  10. Kapral F. A., Godwin J. R., Dye E. S. Formation of intraperitoneal abscesses by Staphylococcus aureus. Infect Immun. 1980 Oct;30(1):204–211. doi: 10.1128/iai.30.1.204-211.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kapral F. A. Staphylococcus aureus: some host-parasite interactions. Ann N Y Acad Sci. 1974 Jul 31;236(0):267–276. doi: 10.1111/j.1749-6632.1974.tb41497.x. [DOI] [PubMed] [Google Scholar]
  12. Leake E. S., Wright M. J., Kreger A. S. In vitro effect of purified proteases of Pseudomonas aeruginosa on rabbit lung macrophages. Exp Mol Pathol. 1978 Oct;29(2):241–252. doi: 10.1016/0014-4800(78)90042-4. [DOI] [PubMed] [Google Scholar]
  13. NAHMIAS A. J., EICKHOFF T. C. Staphylococcal infections in hospitals. Recent developments in epidemiologic and laboratory investigation. N Engl J Med. 1961 Jul 20;265:120–contd. doi: 10.1056/NEJM196107202650305. [DOI] [PubMed] [Google Scholar]
  14. NAHMIAS A. J., EICKHOFF T. C. Staphylococcal infections in hospitals. Recent developments in epidemiologic and laboratory investigation. N Engl J Med. 1961 Jul 27;265:177–concl. doi: 10.1056/NEJM196107272650407. [DOI] [PubMed] [Google Scholar]
  15. Rogolsky M. Nonenteric toxins of Staphylococcus aureus. Microbiol Rev. 1979 Sep;43(3):320–360. doi: 10.1128/mr.43.3.320-360.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thelestam M., Möllby R. Sensitive assay for detection of toxin-induced damage to the cytoplasmic membrane of human diploid fibroblasts. Infect Immun. 1975 Aug;12(2):225–232. doi: 10.1128/iai.12.2.225-232.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wadström T., Möllby R. Some biological properties of purified staphylococcal haemolysins. Toxicon. 1972 Aug;10(5):511–519. doi: 10.1016/0041-0101(72)90177-8. [DOI] [PubMed] [Google Scholar]
  18. van der Vijver J. C., van Es-Boon M. M., Michel M. F. A study of virulence factors with induced mutants of Staphylococcus aureus. J Med Microbiol. 1975 May;8(2):279–287. doi: 10.1099/00222615-8-2-279. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES